Moneycontrol PRO
Loans
Loans
HomeNewsBusinessCompaniesL&T facing labour squeeze at project sites, banking on Gulf returned workers

L&T facing labour squeeze at project sites, banking on Gulf returned workers

Subrahmanyan says they need at least 100,000 workers to ensure the work goes on full throttle.

June 05, 2020 / 23:23 IST

Larsen & Toubro (L&T), India's largest construction and engineering company, said work at its project sites has been affected due to shortage of labour.

"We have 950 (project) sites at any given point of time. At 90 percent of our sites, around 40 percent of labour has left," said SN Subrahmanyan, its CEO and Managing Director.

Around 2,30,000 labourers work across its project sites during normal times, a large proportion of them are migrant workers from north and eastern parts of India. Due to the novel coronavirus, or COVID-19, led lockdown, many of them have returned back to their villages.

Subrahmanyan said they need at least 100,000 workers to ensure the work goes on full throttle.

The management said it is trying to recruit Indian migrant workers returning from the Gulf who have lost their jobs as governments and private investors are cutting back on spending there, battered by the steep fall in crude oil prices. "We are trying to mobilise labour. We expect things to normalise 20-30 days," Subrahmanyan said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

L&T said work at its sites was impacted due to the problems related to supply chain and logistic issues of men and material.

The management said it is not in a position to offer any guidance on order inflow due to uncertain condition, however the company said it will be banking on contracts from states and the Centre, backed by funding from multilateral agencies like World Bank, Asian Development Bank (ADM) and Japan International Cooperation Agency (JIICA).

It also dropped hints of a difficult Q1 FY21.

The consolidated order book of the group stood at Rs 3,03,857 crore as at March end, a year-on-year growth of 4 percent. International orders constituted 25 percent of the total order book.

L&T on June 5 reported a consolidated profit of Rs 3,197 crore for the quarter-ended March, a 6.5 percent decline YoY despite lower tax cost.

Consolidated revenue from operations grew 2.2 percent year-on-year to Rs 44,245.28 crore in Q4 FY20, impacted by COVID-19-led lockdown in the last fortnight of March, while the execution pace was impacted due to clients' liquidity position.

The company's working capital position too slipped in FY20. In FY19 work capital stood at 18 percent to sales, but the same deteriorated to about 23 percent in FY20.

"To some extent, the deterioration is also on account of us allowing vendors to get paid regardless of our customer collections. The terms of trade with all our contracts are increasingly becoming interest linked when it comes customer advances. A combination of these factor has impacted working capital," Shankar Raman, CFO, L&T, said.

On the Schneider deal, Raman said the company is on course to closing the deal. "Once the lockdown is lifted, we should be able to progress and complete pending issues of the transaction."

Viswanath Pilla
Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.
first published: Jun 5, 2020 11:18 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347